Lifastuzumab Biosimilar – Anti-SLC34A2 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product nameLifastuzumab Biosimilar - Anti-SLC34A2 mAb - Research Grade
SourceCAS 1401812-88-1
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsLifastuzumab,DNIB0600A (conjugate),MNIB2126A (non conjugate),SLC34A2,anti-SLC34A2
ReferencePX-TA1334
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Lifastuzumab Biosimilar - Anti-SLC34A2 mAb - Research Grade

General information on Anti-SLC34A2[Homo sapiens] (Lifastuzumab) Monoclonal Antibody

Lifastuzumab is investigated for the treatment of Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer.

SDS-PAGE for Lifastuzumab Biosimilar - Anti-SLC34A2 mAb

Lifastuzumab Biosimilar - Anti-SLC34A2 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Lifastuzumab Biosimilar – Anti-SLC34A2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Sodium-dependent phosphate transport protein 2B(SLC34A2)
Antigen

Sodium-dependent phosphate transport protein 2B(SLC34A2)

PX-P4875 210€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products